한의치료를 받은 갑상선 기능 항진증 환자에 대한 전향적 관찰연구
Prospective Observation Study on Hyperthyroidism Patients Treated with Korean Medicine
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: This is a prospective clinical case study that includes the administration of Ahnjeonbaekho-tang (AJBHT) to patients who have suffered from Graves' disease for the 8 weeks of the clinical research. Methods: Without administration of an antithyroid drug, AJBHT was administered 3 times a day for 8 weeks. In Case 1, AJBHT without modification was administered and in Case 2, in accordance with the patients’ symptoms, a dose of Gypsum Fibrosum was increased by 4g from the beginning of week 2, and further increased by 16 g, for a total of 20 g between week 6 and week 8. Body mass index (BMI), thyroid function test (TFT), thyroid autoantibody test, complete blood cell count (CBC), and blood chemistry (BC) tests were conducted at an interval of 4 weeks, for a total of 3 times during the study. The clinical manifestations, a spectrum of symptoms of the patients, was observed by Wayne’s Index, Euro-QOL-5 Dimension (EQ-5D), and Perceived Stress Scale (PSS). Results: In both cases, an acceptable significance of reduction of value in T3, fT4, Thyroid stimulating antibody (TSAb) and Thyroid stimulating hormone receptor antibody (TSH-R-Ab) was observed. After treatment, in TFT, T3 decreased by 31.66%, fT4 decreased by 32.82% in Case 1, and T3 decreased by 43.42%, and fT4 decreased by 37.32% in Case 2. In the thyroid autoantibody test, TSAb decreased by 7.59%, and TSH-R-Ab decreased by 53.19% in Case 1, and TSAb decreased by 33.45%, TSH-R-Ab decreased by at least 7.75% in Case 2. Besides this, there was a decreasing trend of Wayne’s index, and a loss of typical symptoms of hyperthyroidism also declared the efficacy. Conclusion: From these results, AJBHT is very effective in the regulation of TFT and improving the symptoms of hyperthyroidism, and is also expected to be an effective alternative to antithyroid drugs for patients who have side effects or drug intolerance.
Abstract
Objective: This is a prospective clinical case study that includes the administration of Ahnjeonbaekho-tang (AJBHT) to patients who have suffered from Graves' disease for the 8 weeks of the clinical research. Methods: Without administration of an antithyroid drug, AJBHT was administered 3 times a day for 8 weeks. In Case 1, AJBHT without modification was administered and in Case 2, in accordance with the patients’ symptoms, a dose of Gypsum Fibrosum was increased by 4g from the beginning of week 2, and further increased by 16 g, for a total of 20 g between week 6 and week 8. Body mass index (BMI), thyroid function test (TFT), thyroid autoantibody test, complete blood cell count (CBC), and blood chemistry (BC) tests were conducted at an interval of 4 weeks, for a total of 3 times during the study. The clinical manifestations, a spectrum of symptoms of the patients, was observed by Wayne’s Index, Euro-QOL-5 Dimension (EQ-5D), and Perceived Stress Scale (PSS). Results: In both cases, an acceptable significance of reduction of value in T3, fT4, Thyroid stimulating antibody (TSAb) and Thyroid stimulating hormone receptor antibody (TSH-R-Ab) was observed. After treatment, in TFT, T3 decreased by 31.66%, fT4 decreased by 32.82% in Case 1, and T3 decreased by 43.42%, and fT4 decreased by 37.32% in Case 2. In the thyroid autoantibody test, TSAb decreased by 7.59%, and TSH-R-Ab decreased by 53.19% in Case 1, and TSAb decreased by 33.45%, TSH-R-Ab decreased by at least 7.75% in Case 2. Besides this, there was a decreasing trend of Wayne’s index, and a loss of typical symptoms of hyperthyroidism also declared the efficacy. Conclusion: From these results, AJBHT is very effective in the regulation of TFT and improving the symptoms of hyperthyroidism, and is also expected to be an effective alternative to antithyroid drugs for patients who have side effects or drug intolerance.
참고문헌 (15)
- Burch HB, "Management of Graves Disease: A Review", JAMA, 314(23), pp.2544~2554 (2015)[DOI]
- 이가희, "갑상선기능항진증의 진단 및 치료- 대한갑상선학회 합의안", International Journal of Thyroidology, 6(1), pp.1~11 (2013), 대한갑상선학회
- The Korean Association of Internal Medicine, "Harrison's Principles of Internal Medicine, 17th", pp.2691~ (2012)
- Heidari R, "An Overview on the Proposed Mechanisms of Antithyroid Drugs-Induced Liver Injury", Adv Pharm Bull, 5(1), pp.1~11 (2015)
- 김경원, "항갑상선제 치료 후 그레이브스병의 재발 지표 분석", 대한내과학회지, 72(5), pp.522~528 (2007), 대한내과학회
- Department of internal medicine (Nephro-Endocrine system), College of Korean Medicine, "Nephro-Endocrinology", pp.97~98 (2015), Koonja
- Ahn SY, "Thyroid Gland Clinic", pp.236~237 (2004), Seongbosa
- Shin-Ik Kang, "The Effects of Ahnjeonbaekho-tang on FRTL-5 Cell Proliferation and Thyroxine Synthesis", 대한한방내과학회지, 27(3), pp.653~663 (2006), 대한한방내과학회
- Byun SH, "The Effect of Ahnjeonbaekho-tang on Resistant Graves' Disease : The Prospective Clinical Study", Korean J Orient Int Med, pp.59~65 (2003)
- Kim YS, "The Effect of Ahnjeonbaekho-tang and Ahnjeonbaekho-hwan on Graves' disease; The substitutional effect of Antithyroid drugs", Korean J Orient Int Med, pp.145~151 (2006)
- Kalra S, "Clinical scoring scales in thyroidology: A compendium", Indian J Endocrinol Metab, 15(2), pp.89~94 (2011)[DOI]
- 이중정, "일 지역에서의 EQ-5D를 이용한 고혈압·당뇨병 교육프로그램 이수자의 삶의 질 평가", 농촌의학.지역보건, 39(1), pp.37~45 (2014), 한국농촌의학.지역보건학회[DOI]
- 이종하, "한글판 스트레스 자각척도의 신뢰도와 타당도 연구", 정신신체의학, 20(2), pp.127~134 (2012), 한국정신신체의학회
- Cho BY, "Clinical Thyroidology", pp.256~276 (2014), Korea Medical Book Publishing Company
- Seoul National University College of Medicine, "Endocrinology", pp.147~ (2006), SNUPRESS